It has an exclusive option to repurchase its rights to the three drugs for apresetprice, which it will likely do if the clinical trials succeed on its cholesterol-lowering drug, called 301012.
But they have proved unpopular with some energy suppliers, which say basing them on the difference between the actual market price and apreset, guaranteed price, is overly complex.